Works matching IS 17569966 AND DT 2025 AND VI 1

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD⁺/NADH ratio.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 1, p. 1, doi. 10.1186/s13046-024-03254-x

By:

• Hu, Wentao;
• Cui, Xiaoteng;
• Liu, Hongyu;
• Li, Ze;
• Chen, Xu;
• Wang, Qixue;
• Zhang, Guolu;
• Wen, Er;
• Lan, Jinxin;
• Chen, Junyi;
• Liu, Jialin;
• Kang, Chunsheng;
• Chen, Ling

Publication type:

Article